Company intelligence / Profile preview

IntelGenx

Saint-Laurent, Quebec, Canadaintelgenx.com ↗

Ownership: Public · IGXT
Employees: ~75
Development stage: Other

Overview

IntelGenx has sponsored over three dozen clinical studies with several pivotal trials. Its lead pipeline asset Montelukast VersaFilm® has entered Phase II studies targeting neurodegenerative disorders such as Parkinson's disease. The company also has late-stage or approved products in migraine, erectile dysfunction, schizophrenia, chronic pain/opioid dependence, and cannabinoids. Their proprietary oral thin-film platforms offer improved bioavailability and patient compliance compared to traditional formulations.

Therapeutic areas: OtherMen's HealthPsychiatryNeurology
Modalities: Small moleculePharmaceutical film (oral thin film, transdermal film)CannabinoidsPsychedelic compounds
Industry: Biotech

Drug pipeline

4 assets

INT007

Preclinical

3 more assets in the full pipeline.

Partnerships

atai Life Sciences – financial support/research collaboration on psychedelic therapiesvarious undisclosed pharmaceutical partners

Beyond the preview

Go deeper on IntelGenx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IntelGenx.